By 2025, Self-monitoring Devices held the dominant position in the blood glucose monitoring devices market with a 64.02% share. This segment’s leadership is underpinned by its established use across routine diabetes management, broad familiarity among patients and care providers, and its practical fit for regular point-in-time blood glucose checks. Self-monitoring Devices remain deeply embedded in day-to-day care pathways because they offer a straightforward approach to glucose tracking, especially where periodic testing continues to meet monitoring needs.

Continuous Blood Glucose Monitoring Devices are emerging as the fastest-growing product segment in the blood glucose monitoring devices market as care models increasingly shift toward more frequent and dynamic glucose visibility. Their momentum is being driven by the practical advantage of ongoing monitoring, which supports tighter glucose management and reduces reliance on intermittent manual testing alone. Compared with traditional alternatives, Continuous Blood Glucose Monitoring Devices are experiencing stronger uptake because they align more closely with evolving patient expectations for convenience, continuity, and more responsive diabetes management.

End-use Segment Analysis: Hospitals (Largest Segment) vs Home Care (Fastest-Growing Segment)

Hospitals accounted for the largest position in the blood glucose monitoring devices market in 2025, holding a 43.57% share. Their leadership reflects the continued concentration of diabetes testing and monitoring within structured clinical environments, where blood glucose assessment is integrated into inpatient care, emergency management, and supervised treatment decisions. Hospitals maintain this share because they handle a wide range of cases requiring dependable monitoring workflows, trained staff oversight, and immediate clinical response.

Home Care is the fastest-growing end-use segment in the blood glucose monitoring devices market, underpinned by the broader movement toward decentralized diabetes management. Growth is being reinforced by the practical need for convenient and regular monitoring outside clinical settings, where patients can manage blood glucose more consistently as part of everyday life. Relative to institutional settings, Home Care is gaining momentum because it better fits long-term self-management requirements and the increasing preference for routine monitoring in a personal, non-hospital environment.